Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Phase Ia study with NGD-91-2 completed

Nov. 10, 1997

Prionics develops antibody useful for diagnosing and possibly treating prion diseases

Nov. 10, 1997

Quinoxalinediones for neurodegenerative/neurological disorders patented

Nov. 10, 1997

Takeda describes new melatonin agonists

Nov. 10, 1997

Ganaxolone shows promise in phase II epilepsy and migraine trials

Nov. 10, 1997

Apomorphine designated orphan drug

Nov. 7, 1997

Peripherally acting opioid analgesics described by Astra

Nov. 7, 1997

New neuroprotectants from HHS

Nov. 6, 1997

NIH scientists identify nicotinic receptor in hippocampus

Nov. 6, 1997

Melatonin evaluated for bipolar disorder

Nov. 6, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 30, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...